Acorah Software Products - Accounts Production 19.1.200 false true true 28 February 2025 1 March 2024 false 1 March 2025 28 February 2026 28 February 2026 10003717 Mrs Nidhi Shrivastava Mr Saurabh Shrivastava iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10003717 2025-02-28 10003717 2026-02-28 10003717 2025-03-01 2026-02-28 10003717 frs-core:Non-currentFinancialInstruments 2026-02-28 10003717 frs-core:ShareCapital 2026-02-28 10003717 frs-core:RetainedEarningsAccumulatedLosses 2026-02-28 10003717 frs-bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 10003717 frs-bus:AbridgedAccounts 2025-03-01 2026-02-28 10003717 frs-bus:SmallEntities 2025-03-01 2026-02-28 10003717 frs-bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 10003717 frs-bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 10003717 frs-bus:Director1 2025-03-01 2026-02-28 10003717 frs-bus:Director2 2025-03-01 2026-02-28 10003717 frs-countries:EnglandWales 2025-03-01 2026-02-28 10003717 2024-02-29 10003717 2025-02-28 10003717 2024-03-01 2025-02-28 10003717 frs-core:Non-currentFinancialInstruments 2025-02-28 10003717 frs-core:ShareCapital 2025-02-28 10003717 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28
Registered number: 10003717
REVIVE PHYSIOTHERAPY LTD
Unaudited ABRIDGED Financial Statements
For The Year Ended 28 February 2026
REVIVE PHYSIOTHERAPY LTD
Contents
Contents

| Page
--- | ---
Abridged Balance Sheet | 1—2
Notes to the Abridged Financial Statements | 3—4

Page 1
REVIVE PHYSIOTHERAPY LTD
Abridged Balance Sheet
As At 28 February 2026
Abridged Balance Sheet
Registered number: 10003717

| 2026 | 2025
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
CURRENT ASSETS
Debtors | 6 | 19,655 |  | 10,012 |
Cash at bank and in hand |  | 7,088 |  | 20,259 |
|  | 26,743 |  | 30,271 |
Creditors: Amounts Falling Due Within One Year |  | (25,228 ) |  | (27,964 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 1,515 |  | 2,307
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 1,515 |  | 2,307
NET ASSETS |  |  | 1,515 |  | 2,307
CAPITAL AND RESERVES
Called up share capital | 7 |  | 10 |  | 10
Profit and Loss Account |  |  | 1,505 |  | 2,297
SHAREHOLDERS' FUNDS |  |  | 1,515 |  | 2,307

Page 1
Page 2
REVIVE PHYSIOTHERAPY LTD
Abridged Balance Sheet (continued)
As At 28 February 2026
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 28 February 2026 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board

Mr Saurabh Shrivastava Director
15/06/2026

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
REVIVE PHYSIOTHERAPY LTD
Notes to the Abridged Financial Statements
For The Year Ended 28 February 2026
Notes to the Abridged Financial Statements
1. General Information
REVIVE PHYSIOTHERAPY LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10003717 . The registered office is 27 Beresford Avenue, Surbiton, KT5 9LH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
At the time of approving the financial statement, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts. Turnover includes revenue earned from the sale of the rendering of services.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2025: 2)
2 2
4. Intangible Assets

| Total
--- | ---
| £
Cost
As at 1 March 2025 | 12,000
As at 28 February 2026 | 12,000
Amortisation
As at 1 March 2025 | 12,000
As at 28 February 2026 | 12,000
Net Book Value
As at 28 February 2026 | -
As at 1 March 2025 | -

Page 3
Page 4
REVIVE PHYSIOTHERAPY LTD
Notes to the Abridged Financial Statements (continued)
For The Year Ended 28 February 2026
5. Tangible Assets

| Total
--- | ---
| £
Cost
As at 1 March 2025 | 8,000
As at 28 February 2026 | 8,000
Depreciation
As at 1 March 2025 | 8,000
As at 28 February 2026 | 8,000
Net Book Value
As at 28 February 2026 | -
As at 1 March 2025 | -

6. Debtors

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Due after more than one year
Other debtors | 4,000 |  | 4,000

7. Share Capital

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 10 |  | 10

Page 4